XantheJuliana
2021-12-17

JNJ sure lived up to the hype, “One and done.” 😬

“A panel of outside advisers to the U.S. Centers for Disease Control and Prevention on Thursday voted to recommend Americans choose to receive one of the other two authorized COVID-19 vaccines over Johnson & Johnson's (JNJ.N) shot, due to rare but sometimes fatal cases of blood clotting.”

Just as big a lie as mRNA vaccines efficacy of 95% when they were approved.

Now we know what big pharma knew then.....antibodies and protection peak at day 28 then start dropping like a rock.$Moderna, Inc.(MRNA)$ $Johnson & Johnson(JNJ)$

免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法